Matrix-suppressed laser desorption/ionisation mass spectrometry and its suitability for metabolome analyses.
about
Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in HypoxiaVisualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging.Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion sourceMass spectrometry-based technologies for high-throughput metabolomics.Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.Selective detection of alkaloids in MALDI-TOF: the introduction of a novel matrix molecule.Quantitative analysis of pharmaceutical drug distribution in multiple organs by imaging mass spectrometry.Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS.Recent methodological advances in MALDI mass spectrometry.Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standardsInvestigation of colloidal graphite as a matrix for matrix-assisted laser desorption/ionisation mass spectrometry of low molecular weight analytes.Generation of gas-phase ions from charged clusters: an important ionization step causing suppression of matrix and analyte ions in matrix-assisted laser desorption/ionization mass spectrometry.Monitoring the health to disease continuum with global metabolic profiling and systems biology.Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders.Metabolomics-based methods for early disease diagnosticsThe role of direct high-resolution mass spectrometry in foodomics.FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.The accumulation mechanism of the hypoxia imaging probe "FMISO" by imaging mass spectrometry: possible involvement of low-molecular metabolites.Identification and Quantification of N-Acyl Homoserine Lactones Involved in Bacterial Communication by Small-Scale Synthesis of Internal Standards and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry.
P2860
Q28553813-7AA3B635-BE36-43CE-BEBC-FFF91426A558Q33336616-E4503006-CB41-42A6-9B25-BB3AD24BC0C0Q33725838-664834C6-AFCB-4E11-B804-6033CCA2857EQ33748840-8F617D94-55CF-4F77-B5B2-1BDAFDD8D622Q33888328-3D5334A9-8DFB-4374-9640-94506617CAEFQ34242683-0BDAECBD-74C8-4138-B54B-352B07FD1202Q34283830-EE3599B3-BDC3-4DA0-A9AD-4968EAEE1703Q34593213-F7E9584D-5B70-41AF-82B7-99662EAD8FA4Q35126789-EC9EB261-0BA2-4C68-8A0D-E3302F47429AQ35149911-C963E16D-45AA-4982-95E3-9575E56E6BB8Q36081940-E7033533-D3AC-4B37-B82E-19A9543D0746Q36137029-25F04910-8892-441C-A563-4D68ACA85618Q36630002-9D318A75-ED7F-4085-87A2-E9483C39B109Q36630012-E0678270-01CD-45B6-9052-1912EC0C1E1EQ37266489-704B9802-11A2-4888-9022-E74A62C68B2CQ38542798-AA234B43-C841-437D-A1C1-D5842BDD584FQ42094666-68B03B03-A4F1-4E33-AD80-4E71BFDAD823Q43165279-7BF43E25-3C6D-4339-9990-02F34164C0EBQ48151487-1AC80AF7-7B2A-42C2-93EF-FCFC4194BE8C
P2860
Matrix-suppressed laser desorption/ionisation mass spectrometry and its suitability for metabolome analyses.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@ast
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@en
type
label
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@ast
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@en
prefLabel
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@ast
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@en
P356
P1476
Matrix-suppressed laser desorp ...... ility for metabolome analyses.
@en
P2093
Simon Gaskell
P304
P356
10.1002/RCM.2434
P577
2006-01-01T00:00:00Z